Vofatamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Vofatamab Usage And Synthesis

Uses

Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC)[1].

IC 50

FGFR3

References

[1] Andrea Necchi, et al. Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC). Journal of Clinical Oncology 2019 37:7_suppl, 409-409.

Vofatamab(1312305-12-6)Related Product Information

• Tezepelumab
• Rilotumumab
• Alirocumab
• citatuzumab
• Diridavumab
• Vorsetuzumab
• MGA271
• Research Grade Sofituzumab(DHJ31004)
• Etaracizumab
• Denosumab